ARBITEL TRIO 10MG/25MG/40MG TAB

Overview

ARBITEL TRIO 10MG/25MG/40MG TAB is composed of: TELMISARTAN (40.0 MG), METOPROLOL (25.0 MG), CILNIDIPINE (10.0 MG)

Telmisartan is an angiotensin II receptor antagonist. Telmisartan keeps blood vessels from narrowing, which lowers blood pressure and improves blood flow. Telmisartan is used to treat high blood pressure (hypertension). It is sometimes given together with other blood pressure medications. Telmisartan is also used to reduce the risk of stroke, heart attack, or death from heart problems in people who are at least 55 years old with risk factors for serious heart disorders.

Metoprolol is a beta-blocker that affects the heart and circulation (blood flow through arteries and veins). Metoprolol is used to treat angina (chest pain) and hypertension (high blood pressure). Metoprolol is also used to lower your risk of death or need to be hospitalized for heart failure.

Usage

TELMISARTAN is generally used to treat: Hypertension, Stroke, Heart Attack

METOPROLOL is generally used to treat: Chest Pain, Hypertension, Blood Pressure, High

Frequently Asked Questions

Q: Is it safe on my liver?
A: Check with your Doctor first

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Ask your doctor

Q: Can it be taken during pregnancy?
A: Studies indicate Risk – Doctor advice is must

Q: Is it safe to take for someone breastfeeding?
A: Check with your Doctor first

Precautions for ARBITEL TRIO 10MG/25MG/40MG TAB and its Constituents

Caution should be exercised in patients with history of heart, liver or kidney disease, children, during pregnancy and breastfeeding. It may cause dizziness or drowsiness, do not drive a car or operate machinery while taking this medication. Avoid alcohol consumption while taking this medication. Patients may develop with severe allergic reactions; if it so consult with your doctor. It may cause diarrhea, dehydration, excessive sweating or vomiting which leads to low blood pressure.
Caution should be exercised in patients with history of heart attack, slow or irregular heartbeat, heart failure, chest pain, poor blood circulation, liver impairment, sugar, breathing problems, adrenal gland tumor (pheochromocytoma), any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding. It may cause drowsiness, dizziness, or lightheadedness, do not drive a car or operate machinery while taking this medication. Avoid alcohol consumption. Avoid abrupt withdrawal.

Common Side-Effects

TELMISARTAN : Dizziness, Lightheadedness
METOPROLOL : Diarrhoea, Drowsiness, Dizziness, Fatigue (tiredness), Slow Heart Rate (pulse), Lightheadedness

Serious Side-Effects

TELMISARTAN : Fainting, Weakness (generalized), Irregular Heartbeat

Rare Side-Effects

TELMISARTAN : Skin Rash, Face Swelling, Body Itching, Difficulty Breathing
METOPROLOL : Heart Failure, Skin Rash, Fainting, Difficulty Breathing, Weight Gain, Mood Swings, Confusion, Depressed Mood

Technical Classification

TELMISARTAN is categorized as: ANGIOTENSIN RECEPTOR BLOCKERS / CARDIOVASCULAR AGENTS
METOPROLOL is categorized as: CARDIOSELECTIVE BETA BLOCKERS / BETA-ADRENERGIC BLOCKING AGENTS / CARDIOVASCULAR AGENTS

Available Alternatives for ARBITEL TRIO 10MG/25MG/40MG TAB

What are the commonly available Substitutes?

ARBITEL TRIO 10MG/25MG/40MG TAB	INR 100 for 10 TABLETS	TELMISARTAN 40.0 MG, METOPROLOL 25.0 MG, CILNIDIPINE 10.0 MG
MET XL TRIO 25MG TAB	INR 105 for 10 TABLETS	TELMISARTAN 40.0 MG, METOPROLOL 25.0 MG, CILNIDIPINE 10.0 MG

What are the other drugs with similar Ingredients?

ARBITEL TRIO 10MG/50MG/40MG TAB	INR 125 for 10 TABLETS	METOPROLOL 50.0 MG, TELMISARTAN 40.0 MG, CILNIDIPINE 10.0 MG
MET XL TRIO 50MG TAB	INR 125 for 10 TABLETS	METOPROLOL 50.0 MG, TELMISARTAN 40.0 MG, CILNIDIPINE 10.0 MG